| Pharmaceutical active ingredients: |
| Naphazoline NitrateZinc Sulfate |
| Available forms, composition and doses of Vasoconstr: |
| N / A |
| Vasoconstr medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01AX03 - Zinc compoundsS01GA51 - Naphazoline, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Indaco | Naphazoline Nitrate; Zinc Sulfate | EuPharmed |
| Maxibell | Naphazoline Nitrate; Zinc Sulfate | Latinofarma Indistrias Farmaceuticas |
| Nazin | Naphazoline Nitrate; Zinc Sulfate | Aristo Pharmaceuticals |
| Oculosan N | Naphazoline Nitrate; Zinc Sulfate | Novartis |
| Oculsan | Naphazoline Nitrate; Zinc Sulfate | Novartis |
| Vasoconstricto | Naphazoline Nitrate; Zinc Sulfate | Alcon |
| Vastrictol | Naphazoline Nitrate; Zinc Sulfate | Allergan |
| Visurex | Naphazoline Nitrate; Zinc Sulfate | Aristo Pharmaceuticals; Sincerity Asia |
| Zabysept | Naphazoline Nitrate; Zinc Sulfate | Rafarm |
| Zinc-Imizol | Naphazoline Nitrate; Zinc Sulfate | Farmigea Industria Chimico Farmaceutica |